Canada· CA-DIN-02518252
VABLYS
A dequalinium product containing dequalinium chloride, registered in Canada by DUCHESNAY INC. The same ATC class is registered in 9 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Dequalinium is registered in 9 of 19 countries.
Countries holding a registration under ATC G01AC05 (dequalinium), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Dequalinium · ATC G01AC05
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of dequalinium costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dequalinium · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$5.10
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DEQUALINIUM CHLORIDE
- Manufacturer
- DUCHESNAY INC
- Country
- Canada (CA)
- ATC code
- G01AC05
- ATC class
- Dequalinium
- Defined daily dose
- 10 mg, V
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dequalinium in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandDonaxylOrifarm Oy
- SwedenDonaxyl 10 mg VaginaltablettEbb Medical AB
- BelgiumFluomizin 10 mgGedeon Richter
- NorwayDonaxylCampusPharma AB
- PolandFluomizinGedeon Richter Polska Sp. z o.o.
- United KingdomFluomizin 10mg vaginal tabletsGedeon Richter (UK) Ltd
- CzechiaNAXYLVIVAX Pharmaceuticals, s.r.o., Povážská Bystrica
- GermanyDequalinium Chloride RatiopharmRatiopharm Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Fluomizin, Tonsillol
- Belgium · Fluomizin
- Bulgaria · Флуомизин
- Czechia · Naxyl
- Germany · Dequalinium Chloride Ratiopharm, Fluomizin
- Estonia · Donaxyl
- Spain · Fluomizin
- Finland · Donaxyl
- France · Vablys
- United Kingdom (Northern Ireland) · Fluomizin
- Croatia · Fluomizin
- Hungary · Fluomizin
- Italy · Coryfin Gola, Dequadin
- Lithuania · Donaxyl
- Luxembourg · Fluomizin
- Latvia · Donaxyl
- Norway · Donaxyl
- Poland · Fluomizin
- Portugal · Fluomizin
- Romania · Fluomizin
- Sweden · Donaxyl
- Slovenia · Fluomizin
- Slovakia · Fluomizin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/46169064-c3de-4ee0-a4c2-948ce87b42af GET /v1/drugs/46169064-c3de-4ee0-a4c2-948ce87b42af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02518252",
"form": "VAGINAL TABLET",
"class": "Human",
"routes": [
"VAGINAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "G01AC05",
"schedule": [
"Prescription"
],
"drug_code": "100757",
"strengths": [
"10 MG"
],
"ahfs_class": null,
"substances": [
"DEQUALINIUM CHLORIDE"
],
"product_categorization": null
}See everything about dequalinium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.